20 completed, 2 unknown, 1 active not recruiting. 10 Not applicable, 7 Phase 3, 6 Phase 1.
By phase and status
Follow Geropharm: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®. GP40221, ozempic - Pharmacokinetics, Safety Issues | Phase 1 | Completed | 120 | 2023-06-30 | 2024-07-11 |
Evaluation of Insulin Glulisine (GP40321) Compared to Insulin Glulisine (Apidra® SoloStar®) in Type 1 Diabetes Mellitus Patients GP40321, Apidra® SoloStar®, RinGlar® - Type 1 Diabetes Mellitis | Phase 3 | Completed | 224 | 2023-04-14 | 2025-07-22 |
Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia GP404141, Nplate - Drug Effect, Safety Issues | Phase 3 | Active not recruiting | 160 | 2023-04-04 | 2024-07-11 |
Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141 GP40141, Nplate - Pharmacodynamics, Pharmacokinetics | Phase 1 | Unknown | 56 | 2022-06-03 | 2022-12-15 |
Pharmacokinetics, Safety and Efficacy Study of GP30341 (GEROPHARM, Russia) GP30341 capsules 200 mg, Standard therapy - Pharmacokinetics, Safety Issues | Not applicable | Completed | 246 | 2022-03-17 | 2024-07-22 |
Efficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus Patients GP40081, NovoMix 30 - Diabetes Mellitus, Type 2, Diabetes Mellitus | Phase 3 | Unknown | 264 | 2020-01-20 | 2020-04-15 |
Bioequivalence Study of GP30101 800 mg (GEROPHARM) Versus PREZISTA® 800 mg ("Jonson&Jonson", Russia) GP30101, Prezista® - Bioequivalence | Not applicable | Completed | 44 | 2019-06-06 | 2024-07-22 |
Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients GP40071, NovoRapid® Penfill® - Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Completed | 264 | 2019-06-03 | 2020-07-23 |
A Study to Compare Pharmacokinetics and Pharmacodynamics of GP-40081 to NovoMix® 30 Penfill® in Healthy Subjects GP-40081, NovoMix® 30 Penfill® - Clamp Study | Not applicable | Completed | 34 | 2019-04-15 | 2019-12-03 |
A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy Subjects Insulin Aspart, NovoRapid® Penfill® - Clamp Study | Not applicable | Completed | 26 | 2018-10-18 | 2019-12-03 |
Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients Lantus Solostar, 100 Units/mL Subcutaneous Solution, Insulin RinGlar, 100 Units/mL Subcutaneous Solution - Diabetes Mellitus, Type 1, Diabetes Mellitus | Phase 3 | Completed | 180 | 2018-07-04 | 2019-07-17 |
Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects Bosentan 125 mg, Tracleer 125Mg Tablet - Bioequivalence | Phase 1 | Completed | 64 | 2018-05-24 | 2019-09-24 |
Efficacy and Safety of Insulin Lispro Biphasic 25 Compared to Humalog® Mix 25 in Type 2 Diabetes Mellitus Patients Humalog Mix25, Insulin Lispro Biphasic 25 - Diabetes Mellitus, Type 2, Diabetes Mellitus | Phase 3 | Completed | 210 | 2018-03-14 | 2019-07-17 |
Comparative Study of Rinsulin R (GEROPHARM) and Humulin Regular (Eli Lilly) Euglycemic Hyperinsulinemic Clamp Method Humulin® Regular, Rinsulin® R - Bioequivalence, Therapeutic Equivalency | Not applicable | Completed | 20 | 2018-02-19 | 2023-09-22 |
Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method Rinsulin NPH, Humulin NPH - Pharmacokinetics, Bioequivalence | Not applicable | Completed | 52 | 2017-10-23 | 2020-08-06 |
A Study to Compare Pharmacokinetics and Pharmacodynamics of RinGlar® to Lantus® in Type 1 Diabetes Mellitus Patients RinGlar®, Lantus® - Clamp Study | Not applicable | Completed | 42 | 2017-10-16 | 2019-09-24 |
Comparative Study of the Pharmacokinetics of Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, 100 IU / ml (OJSC GEROPHARM-Bio, Russia) and Humulin® M3, Suspension for Subcutaneous Administration, 100 IU / ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method Rinsulin® mix 30/70, Humulin® M3 - Bioequivalence | Not applicable | Completed | 32 | 2017-07-18 | 2020-08-05 |
Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and Fed Conditions Metformine, Glucophage® Long, Metformin - Bioequivalence | Phase 1 | Completed | 28 | 2017-06-15 | 2018-07-03 |
Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients Insulin Humulin® NPH, Insulin Rinsulin® NPH - Diabetes Mellitus, Type 2 | Phase 3 | Completed | 201 | 2017-04-20 | 2019-07-09 |
A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Lispro Mix 25 to Humalog® Mix 25 in Healthy Subjects Insulin Lispro Mix 25, Humalog® Mix 25 - Clamp Study | Not applicable | Completed | 48 | 2017-04-12 | 2018-07-31 |
Showing 20 of 23. Sign in to see all of them.
Conditions studied
Diabetes Mellitus (5) · Insulin Resistance (4) · Diabetes Mellitus, Type 2 (3) · Fasting (3) · Diabetes Mellitus, Type 1 (2) · Lecithin Cholesterol Acyltransferase Deficiency (2) · COVID-19 (1)
Interventions
Insulin Glargine (3) · Insulin Aspart (2) · Metformin (2) · insulin aspart, insulin aspart protamine drug combination 30:70 (2) · romiplostim (2) · Bosentan (1) · Darunavir (1) · Drug Evaluation (1) · Insulin Lispro (1) · Isophane Insulin, Human (1) · Memantine (1) · Standard of Care (1) · Tablets (1) · insulin glulisine (1) · insulin lispro, isophane insulin lispro drug combination (25:75) (1)
Countries
Russia (23)
Top investigators
Aleksandr Yu Mayorov, MD (1) · Bulat Bakirov, MD (1) · Dmitry Kirtbaya (1) · Elena Borisenkova (1) · Elizaveta Antonova (1) · Galina Salogub (1) · Igor Davydkin (1) · Igor Makarenko, MD, PhD (1) · Igor Mr Makarenko, PhD (1) · Lubov Shpagina, MD (1) · Olga A Miroshnichenko, PhD (1) · Olga Vinogradova (1) · Sergei Mr Noskov, AP of medicine (1) · Sergei Noskov, MD, Pr. (1) · Sergey M Noscor, MD, Doctor of science (1)
Results publications
PMID 32027167, PMID 33355484, PMID 33928797, PMID 37740581, PMID 40708707, PMID 41366610